Implications of inhibition of Rev1 interaction with Y family DNA polymerases for cisplatin chemotherapy.

Yoon, Jung-Hoon; Johnson, Robert E; Prakash, Louise; Prakash, Satya

Yoon, Jung-Hoon; Johnson, Robert E; Prakash, Louise; Prakash, Satya.

Afiliação

Yoon JH; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas 77555, USA.
Johnson RE; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas 77555, USA.
Prakash L; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas 77555, USA.
Prakash S; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas 77555, USA.

Genes Dev ; 35(17-18): 1256-1270, 2021 09 01.

Article em En | MEDLINE | ID: mdl-34385260

Assuntos

Cisplatino; Dano ao DNA; Cisplatino/farmacologia; Reparo do DNA; Replicação do DNA; DNA Polimerase Dirigida por DNA/metabolismo; Proteínas Nucleares/metabolismo; Nucleotidiltransferases/genética; Nucleotidiltransferases/metabolismo

Palavras-chave

DNA repair; Rev1; Y family DNA polymerases; cisplatin intrastrand cross-links; nucleotide excision repair; translesion synthesis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dano ao DNA / Cisplatino Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google